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Oxysterols are oxygenated derivatives of cholesterol. They are intermediates in cholesterol
excretion pathways and may also be regarded as transport forms of cholesterol. The
introduction of additional hydroxyl groups to the cholesterol skeleton facilitates the flux of
oxysterols across the blood brain barrier, and oxysterols have been implicated in mediating a
number of cholesterol-induced metabolic effects. Oxysterols are difficult to analyze by
atmospheric pressure ionization mass spectrometry on account of the absence of basic or acidic
functional groups in their structures. In this communication, we report a method for the
derivatization and analysis of oxysterols by electrospray mass spectrometry. Oxysterols with
a 3-hydroxy-5 structure were converted by cholesterol oxidase to 3-oxo-4 steroids and then
derivatized with the Girard P reagent to give Girard P hydrazones, which were subsequently
analyzed by tandem mass spectrometry. The improvement in sensitivity for the analysis of
25-hydroxycholesterol upon oxidation and derivatization was over 1000. (J Am Soc Mass
Spectrom 2006, 17, 341–362) © 2006 American Society for Mass SpectrometryT he introduction of an oxygen function in thecholesterol (C5-3-ol) molecule with the forma-tion of an oxysterol is the first step in choles-
terol degradation pathways [1, 2]. The quantitatively
most important catabolic pathway is the subsequent
conversion of the oxysterol into water-soluble bile
acids. However, other oxysterols are intermediates in
the formation of steroid hormones. Oxysterol forma-
tion can occur in many tissues and organs, and
conversion of an oxysterol to a bile acid is not
restricted to the liver [3–7]. Hormonally active ste-
roids can also be synthesized from cholesterol outside
the endocrine organs. Some oxysterols are ligands to
nuclear receptors, e.g., the liver X receptor (LXR) 
and , and are considered to have important roles in
the regulation of cholesterol and lipid metabolism
and homeostasis [8 –15]. Some oxysterols have been
proposed to mediate inflammatory events in the
development of atherosclerotic lesions [16]. A variety
of oxysterols are found in blood and tissues, exem-
plified by 27-hydroxycholesterol (C5-3,27-diol), 7-
hydroxycholesterol (C5-3,7-diol), 24S-hydroxycho-
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doi:10.1016/j.jasms.2005.10.012lesterol (C5-3,24S-diol), and 4-hydroxycholesterol
(C5-3,4-diol) (see Scheme 1 for steroid skeleton and
numbering system). The levels in plasma of healthy
subjects vary between about 30 and 150 ng/mL.
Minor oxysterols include 25-hydroxycholesterol (C5-
3,25-diol), 7-hydroxycholesterol (C5-3,7-diol),
7-oxocholesterol (C5-3-ol-7-one), cholesterol-5,6-
epoxides (C-3-ol-5,6-epoxide), cholestane-3,5,6-tri-
ols (C-3,5,6-triol) [2]. The levels of these compounds
are usually below 10 ng/mL. Other oxysterols that
have been found, e.g. in brain, include 20-hydroxy-
cholesterol (C5-3,20-diol) and 22-hydroxycholesterol
(C5 -3 ,22-diol) [17, 18]. There is always some doubt
with respect to the origin of the minor oxysterols as
they can be formed by non-enzymatic oxidation of
cholesterol [2]. Oxysterols are present in only trace
amounts in biological systems, where the excess of
cholesterol is invariably more than three orders of
magnitude.
Oxysterols with a 3,7-dihydroxy-5-ene structure
can be oxidized to the corresponding 7-hydroxy-4-en-
3-ones, and 27-hydroxylated oxysterols can be con-
verted to 27-carboxylic acids both in the liver and
extrahepatically. Examples of such metabolites occur-
ring in human circulation are 7-hydroxycholest-4-en-
3-one (C4-7-ol-3-one), 3-hydroxycholest-5-en-27-oic
acid (CA5-3-ol), 3,7-dihydroxycholest-5-en-27-oic
acid (CA5-3,7-diol), and 7-hydroxy-3-oxo-cholest-4-
en-27-oic acid (CA4-7-ol-3-one) (Scheme 1). Because of
their structures and since some of them have regulatory
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terols [19] (or bind to nuclear receptors), it is logical to
extend the term oxysterol to include these types of
compounds.
Oxysterols are widely distributed in tissues and cells.
Their localization is partly related to their structures
and sites of formation. For example, 7-hydroxycholes-
terol is exclusively formed in the liver by the action of
CYP7A1. Its formation is the regulated, rate-limiting
step in bile acid biosynthesis and the levels of 7-
hydroxycholesterol and 7-hydroxycholest-4-en-3-one
in the circulation are positively correlated to the activity
of CYP7A1 in the liver [20 –22]. 27-Hydroxycholesterol,
the quantitatively dominant oxysterol in the circulation
of adult humans (120 ng/mL plasma) is formed by
the action of CYP27A1 which has a broad substrate
specificity and is present in most tissues [1, 2]. The
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Scheme 1. Nuclear skeletons and side-chain structures on which
sterols and oxysterols are based. For example, in cholesterol
(C5-3-ol) the side-chain R1 is attached to the 3-hydroxy-
5
nucleus; in 3-hydroxycholest-5-en-27-oic acid (CA5-3-ol) the
side-chain R2 is attached to the 3-hydroxy-
5 nucleus; in cholest-
4-en-3-one (C4-3-one) the side-chain R1 is attached to the 3-oxo-
4
nucleus, in 3-hydroxychol-5-en-24-oic acid (BA5-3-ol) the side-
chain R3 is attached to the 3-hydroxy-
5 nucleus; and in 3-
hydroxy-5-oxo-5,6-secocholestan-6-al (5,6-seco-sterol) R1 is at-
tached to the 3-hydroxy-5-oxo-5,6-seco-6-al nucleus. The C24 bile
acid side-chain is shown for comparison.3-hydroxycholest-5-en-27-oic acid in human plasma(formed from 27-hydroxycholesterol [23]) originates
mostly from the lung [7]. 24S-Hydroxycholesterol in the
human circulation originates mainly from the brain,
where it is formed by the action of CYP46A1 [24]. While
7-hydroxycholesterol, 27-hydroxycholesterol and 3-
hydroxycholest-5-en-27-oic acid are efficiently con-
verted into bile acids in the liver, about half of the
24S-hydroxycholesterol formed in humans is excreted
in bile in a sulphated or glucuronidated form. This
illustrates that oxysterols, besides being in the free form
(and as fatty acid esters), can occur in different conju-
gated forms. It has been shown recently that that
24S-hydroxycholesterol can be further metabolized into
24,27-dihydroxycholesterol (C5-3,24,27-triol) in man
[25]. 4-Hydroxycholesterol is formed by the action of
CYP3A4 [26], the major cytochrome P450 in human
liver. The metabolic end products of 4-hydroxycholes-
terol have yet to be defined.
Besides known naturally occurring oxysterols, a
large number of synthetic oxysterols have been shown
to be potential ligands to nuclear receptors. It is not
known if some of these occur naturally, and there is a
need for methods to make comprehensive studies of the
nature and levels of oxysterols in tissues and body
fluids. This is illustrated by the recent identification of
novel oxysterols, formed from cholesterol by the action
of ozone, in human tissues [27–30]. Evidence has been
presented for their involvement in the mediation of
inflammatory processes associated with the develop-
ment of atherosclerotic lesions [28], and in the initiation
of protein misfolding as occurs in several neurological
diseases [29]. Of these products, 3-hydroxy-5-oxo-5,6-
secocholestan-6-al (5,6-seco-sterol), a ketoaldehyde, and
its aldol condensation product both contain a reactive
aldehyde group (Scheme 1). Incubation of 5,6-seco-
sterol, or its aldol, with amyloid  peptide (A) leads to
amyloidogenesis, possibly by condensation with amino
groups in the peptide [29]. The levels of the 5,6-seco-
sterol and its aldol were surprisingly high in brain of
patients with Alzheimer’s disease and healthy subjects
[combined seco-sterol levels 0.44 pmol/mg (180
ng/g) and 0.35 pmol/mg (150 ng/g), respectively].
Biologically active oxysterols are also formed during
ozonolysis of cholesterol in lung surfactant [30]. Pulfer
and Murphy [30] identified the major cholesterol de-
rived ozonolysis product in lung surfactant as 5,6-
epoxycholesterol (C-3-ol-5,6-epoxide). In studies of
the metabolism of this oxysterol in lung epithelial cells
they found small amounts of the expected metabolite
cholestane-3, 5, 6-triol (C-3, 5, 6-triol), and more
abundant levels of the unexpected metabolite 3, 5-
dihydroxycholestan-6-one (C-3, 5-diol-6-one). Signif-
icantly, both 5, 6-epoxycholesterol and 3, 5-dihy-
droxycholestan-6-one were shown to be cytotoxic to
human bronchial epithelial cells.
Traditionally, oxysterols have been analyzed by iso-
tope-dilution gas-chromatography-mass spectrometry
(GC-MS) [31, 32]. However, high-performance liquid
chromatography (HPLC) methods have been intro-
343J Am Soc Mass Spectrom 2006, 17, 341–362 ES-MS/MS OF OXYSTEROLSduced in which oxysterols are converted to their
3-oxo-4 derivatives which are then analyzed and de-
tected using their UV chromophore at 205-210 or 240
nm [33, 34]. In the current study, we have followed an
analogous methodology whereby steroids with a 3-
hydroxy-5 structure have been converted to their
3-oxo-4 oxidation products by treatment with choles-
terol oxidase [35–37], and then reacted with Girard P
(GP) reagent to give GP hydrazones [38, 39]. Girard
hydrazones possess a quaternary nitrogen and are
readily analyzed by electrospray (ES) mass spectrome-
try [35– 45]. Furthermore, tandem mass spectrometry
(MS/MS) provides high sensitivity and structural infor-
mation for GP hydrazone analysis. Griffiths et al. were
able to obtain structurally informative ES-MS/MS spec-
tra for steroid GP hydrazones from sub-pg quantities of
sample [38, 39]. In the current study we have explored
the MS/MS fragmentation patterns of a series of oxys-
terol GP hydrazones, and evaluated the potential of
these derivatives for analyzing oxysterols in biological
samples. We have also optimized the enzymatic con-
version of oxysterols to their 3-oxo-4 analogs under
conditions compatible with subsequent ES analysis, and
also optimized the derivatization reaction so as to be
suitable for labile steroids, i.e., 7-hydroxy-4-3-oxo-
steroids. The methodology was tested in an analysis of
an oxysterol fraction from rat brain.
Experimental
Materials
Solvents were of analytical grade. Water was from a
Milli-Q water system (Millipore, Molsheim, France). The
oxysterols 7-hydroxycholesterol, 24S-hydroxycholes-
terol, 20R,22R-dihydroxycholesterol (C5-3,20R,22R-triol),
and 22-oxocholesterol (C5-3-ol-22-one) were kind gifts
from Professor I. Björkhem of the Division of Clinical
Chemistry, Karolinska Institutet. Other oxysterols and
steroids, i.e., 25-hydroxycholesterol, 27-hydroxycholes-
terol, [16,16,17(or 20),22,22,23,23-2H7]27-hydroxycholes-
terol ([2H7]C
5-3,27-diol), 7,25-dihydroxycholesterol (C5-
3,7,25-triol), 7,25-dihydroxycholesterol (C5-3,7,25-
triol), 7,27-dihydroxycholesterol (C5-3,7,27-triol),
[16,16,17(or 20),22,22,23,23-2H7] 7,27-dihydroxycholes-
terol ([2H7]C
5-3,7,27-triol), [16,16,17(or 20),22,22,23,23-
2H7] 3-hydroxycholest-5-en-27-oic acid ([
2H7]CA
5-3-ol),
[16,16,17(or 20),22,22,23,23-2H7] 3,7-dihydroxycholest-
5-en-27-oic acid ([2H7]CA
5-3,7-diol), [16,16,17(or 20),
22,22,23,23-2H7] 3,7-dihydroxycholest-5-en-27-oic acid
methyl ester ([2H7]CA
5-3,7-diol-27-methyl ester), 3,7-
dihydroxycholest-5-en-27-oic acid (CA5-3,7-diol), 3-
hydroxychol-5-en-24-oic acid (BA5-3-ol), [2,2,4,4,23-2H5]
3-hydroxychol-5-en-24-oic acid ([2H5]BA
5-3-ol), 3,7-
dihydroxychol-5-en-24-oic acid (BA5-3,7-diol), [2,2,4,
4,23-2H5] 3-hydroxychol-5-en-24-oylglycine ([
2H4]BA
5-
3-ol-24-oylglycine), cholesterol (C5-3-ol), desmosterol
(C5,24-3-ol), sitosterol (C5-24-ethyl-3-ol), stigmasterol
(C5,22-24-ethyl-3-ol), testosterone (A4-17-ol-3-one), and[19,19,19-2H3] testosterone were from previous studies in
the Karolinska laboratory (Table 1) [38, 39, 46].
Oxidation of 3-Hydroxy-5 Sterols to 3-Oxo-4
Sterols
The 3-hydroxy-5 sterols (and bile acids and steroids)
were oxidized with cholesterol oxidase essentially as
described by Brooks et al. [47]. Recombinant, lyophi-
lized, cholesterol oxidase from Brevibacterium was ob-
tained from Roche Diagnostics GmbH, Mannheim, Ger-
many, through the courtesy of Dr. Ingo Preuss. The
enzyme from Brevibacterium was selected since, in con-
trast to the common enzyme from Nocardia, it also
catalyzes the oxidation of 3-hydroxy-5 steroids of the
C19 and C21 series [48]. Steroids of the latter type are
important intermediates in steroid hormone biosynthe-
sis with biological functions, e.g., as neurosteroids in
brain [49, 50]. The 3-hydroxy-5 sterols (1 g) were
dissolved in 50 L of isopropanol, and 10 L of choles-
terol oxidase (1 mg/mL, 20U/mg protein) in 1 mL of
buffer (50 mM KH2PO4, pH 7) was added; the mixture
was incubated at room temperature (25 °C for 2 to 12 h)
and subsequently used as the starting solution for
reaction with the GP reagent as described below. In
initial experiments designed to study the extent of the
oxidation reaction (primarily using bile acids), the en-
zyme reaction was stopped after overnight incubation
by the addition of 1 mL of methanol, and passed
through a Sep-Pak C18 cartridge (100 mg, Waters,
Milford, MA) prepared in water. The effluent and a 1
mL water-wash were combined and passed again
through the same Sep-Pak cartridge. After washing
with 1 mL of 20% methanol the 3-oxo-4 sterols were
eluted with 2  1 mL of methanol, and 1 mL chloro-
form/methanol, 1:1 (vol/vol), if needed.
Derivatization of Oxosterols
The derivatization of oxosterols to GP hydrazones was
carried out essentially as described by Shackleton et al.
[40] and by Wheeler [51]. The reaction mixture from the
oxidation step above was used directly after the incu-
bation without any further treatment. The oxidation
mixture, 1 mL (50 mM phosphate buffer, 5% isopropa-
nol, 10 g enzyme and 1 g sterols) was diluted with 2
mL of methanol to give a 70% methanol solution, and
150 mg of GP hydrazine (Sigma-Aldrich, Poole, Dorset,
UK) and 150 L of glacial acetic acid were added. The
mixture was left at room temperature overnight.
In initial studies, when the derivatization reaction
was applied to reference compounds, the next step was
to dry the steroid GP hydrazone under a stream of
nitrogen gas and reconstitute in a solution of 10%
aqueous methanol (1 mL). The steroid GP hydrazone
was then separated from excess reagent by extraction
on a Sep-Pak C18 cartridge. After washing with 10%
A -
344 GRIFFITHS ET AL. J Am Soc Mass Spectrom 2006, 17, 341–362aqueous methanol (2 mL), the GP hydrazone was eluted
from the cartridge with methanol (1 or 2 mL).
The solid-phase extraction step above was modified
for the analysis of oxysterols from brain, and the
modified procedure was then subsequently used in all
further studies. Therefore, for brain samples (and for
reference compounds) the GP reaction mixture (3 mL
70% methanol) after overnight incubation was directly
applied to a Sep-Pak C18 bed (1 cm  0.8 cm in a glass
Table 1. Steroids and oxysterols analyzed as GP hydrazones
Name Abbreviation
Cholesterol C5-3-ol
Desmosterol C5,24-3-ol
Sitosterol C5-24-ethyl-3-ol
Stigmasterol C5,22-24-ethyl-3-ol
7-hydroxycholesterol C5-3,7-diol
24-hydroxycholesterol C5-3,24-diol
25-hydroxycholesterol C5-3,25-diol
27-hydroxycholesterol C5-3,27-diol
[16,16,17(or20),22,22,23,
23-2H7] 27-
hydroxycholesterol
[16,16,17(or20),22,22,23,
23-2H7]C
5-3,27-
diol
22-oxocholesterol C5-3-ol-22-one
22-oxocholesterol C5-3-ol-22-one
20R,22R-dihydroxycholesterol C5-3,20R,22R-triol
7,25-dihydroxycholesterol C5-3,7,25-triol
7,25-dihydroxycholesterol C5-3,7,25-triol
7,27-dihydroxycholesterol C5-3,7,27-triol
[16,16,17(or20),22,22,23,
23-2H7] 7,27-
dihydroxycholesterol
[16,16,17(or20),22,22,23,
23-2H7]C
5-
3,7,27-triol
[16,16,17(or20),22,22,23,
23-2H7] 3-hydroxycholest-5-
en-27-oic acid
[16,16,17(or20),22,22,23,
23-2H7]CA
5-3-ol
[16,16,17(or20),22,22,23,
23-2H7] 3,7-
dihydroxycholest-5-en-27-oic
acid
[16,16,17(or20),22,22,23,
23-2H7]CA
5-3,7-
diol
[16,16,17(or20),22,22,23,
23-2H7] 3,7-
dihydroxycholest-5-en-27-oic
acid
[16,16,17(or20),22,22,23,
23-2H7]CA
5-3,7-
diol
[16,16,17(or20),22,22,23,
23-2H7] 3,7-
dihydroxycholest-5-en-27-oic
acid methyl ester
[16,16,17(or20),22,22,23,
23-2H7]CA
5-3,7-
diol-27-methyl
ester
[16,16,17(or20),22,22,23,
23-2H7] 3,7-
dihydroxycholest-5-en-27-oic
acid methyl ester
[16,16,17(or20),22,22,23,
23-2H7]CA
5-3,7-
diol-27-methyl
ester
3-hydroxychol-5-en-24-oic
acid
BA5-3-ol
[2,2,4,4,23-2H5] 3-hydroxychol-
5-en-24-oic acid
[2,2,4,4,23-2H5]BA
5-
3-ol
[2,2,4,4,23-2H5] 3-hydroxychol-
5-en-24-oylglycine
[2,2,4,4,23-2H5]BA
5-
3-ol-24-
oylglycine
3,7-dihydroxychol-5-en-24-
oic acid
BA5-3,7-diol
Testosterone3 A4-17-ol-3-onecolumn) followed by 1 mL of 70% methanol and 1 mLof 35% methanol. The combined effluent (now 5 mL)
was diluted with 4 mL of water. The resulting mixture
(now 9 mL in 35% methanol) was again applied to the
column followed by a wash with 1 mL of 17%methanol.
To the combined effluent 9 mL of water was added. The
sample was then in 19 mL of about 17.5% methanol.
This was again applied to the column followed by a
wash with 10 mL of 10% methanol. Now all the GP
derivatives are extracted by the column. They were then
xidation product Mass of GP Cmpd (MS/MS Fig4)
3-one 518.41 I (3c)
24-3-one 516.40 II (S-4b)
24-ethyl-3-one 546.44 III (S-4c)
22-24-ethyl-3-one 544.43 IV (S-4d)
7-ol-3-one 534.41 V (2e)
24-ol-3-one 534.41 VI (2a)
25-ol-3-one 534.41 VII (2c)
27-ol-3-one 534.41 VIII (2d)
,16,17(or20),22,22,23,
3-2H7]C
4-27-ol-3-
ne
541.45 IX
3,22-dione 532.391 X (2f)
3,22-dione 666.462 XI (2g)
20R,22R-diol-3-
ne
550.40 XII (3b)
7,25-diol-3-one 550.40 XIII (S-1c)
7,25-diol-3-one 550.40 XIV (S-1d)
7,27-diol-3-one 550.40 XV (3a)
,16,17(or20),22,22,23,
3-2H7]C
4-7,27-
iol-3-one
557.44 XVI (S-1b)
,16,17(or20),22,22,23,
3-2H7]CA
4-3-one
555.43 XVII (S-2a)
,16,17(or20),22,22,23,
3-2H7]CA
4-7-ol-
-one
571.42 XVIII (S-2b)
,16,17(or20),22,22,23,
3-2H7]CA
4-7-ol-
-one
571.42 XIX (S-2c)
,16,17(or20),22,22,23,
3-2H7]CA
4-7-ol-
-one-27-methyl
ster
585.44 XX
,16,17(or20),22,22,23,
3-2H7]CA
4-7-ol-
-one-27-methyl
ster
585.44 XXI (S-2d)
4-3-one 506.34 XXII (S-3a)
,4,23-2H4]BA
4-3-
ne
510.36 XXIII (S-3b)
,4,23-2H4]BA
4-3-
ne-24-oylglycine
567.38 XXIV (S-3c)
4-7-ol-3-one 522.33 XXV (S-3d)
17-ol-3-one 422.28 XXVIO
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4eluted with two 1 mL portions of methanol followed by
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fractions were analyzed separately by ES mass spec-
trometry. The GP derivatives were found predomi-
nantly in the second mL of methanol and the results of
the analysis of this fraction are described below.
The derivatization protocol has been applied to mix-
tures of oxosteroids on the g-ng level and is suitable
for the low level (pg) derivatization of neutral steroids
extracted from tissue [36, 37].
Extraction of Oxysterols from Brain
In brief, oxysterols were extracted from 100 mg of rat
brain as follows: 100 mg of brain was homogenized in
ethanol (1 mL), the ethanol extract was centrifuged and
the supernatant retained. The precipitate was ultrasoni-
cated in 1 mL of methanol/dichloromethane (1:1, vol/
vol), centrifuged and the supernatant added to that
retained previously. The combined supernatants were
dried and redissolved in 2 mL of methanol/dichlo-
romethane/water (7:2:1, vol/vol). This solution was
added to a Lipidex DEAP (diethylaminohydroxypropyl
Table 1. (Continued)
Name Abbreviation
[19,19,19-2H3] testosterone
3 [19,19,19-2H3]A
4-
17-ol-3-one
1. mono-GP hydrazone
2. bis-GP hydrazone
3. not treated with cholesterol oxidase
4. MS/MS Figure number, S refers to supplementary material
HO
cholesterol skeleton  C5-3β-ol
12
3 4
5 6 7
8910
19 11
12
13
14
15
16
17
18 20
21
22
23
24
25
27
26
HO 
3 β -hydroxycholest-5-en-27-oic acid skeleton  CA 5 -3 β -ol 
1 2 
3 4 
5 6 7 
8 9 10 
19 11 
12 
13 
14 
15 
16 
17 
18 20 
21 
22 
23 
24 
25 
OH 
O Sephadex LH-20, PerkinElmer, Beaconsfield, Bucks,UK) anion-exchange column in its acetate form [50] (7 
0.4 cm) prepared in methanol/dichloromethane/water
(7:2:1, vol/vol). The column was washed with 2 mL of
the same solvent, followed by 1 mL of methanol/
dichloromethane/water (2:2:1, vol/vol), and the “flow-
through” and “wash” combined, dried, and redissolved
in 2 mL of hexane/dichloromethane (2:8, vol/vol). This
“neutral fraction” was then applied to a Unisil column
(8  0.8 cm, 200–325 mesh, activated silicic acid, Clark-
son Chromatography Products, Inc., South William-
sport, PA) prepared in hexane, and washed with 20 mL
of hexane/dichloromethane (2:8, vol/vol) before sam-
ple application. Following sample application the col-
umn was washed with 80 mL of hexane/dichlorometh-
ane (2:8, vol/vol), and eluted with 10 mL of
ethylacetate. The eluate was dried and redissolved in 50
L isopropanol, and used as described above.
Mass Spectrometry
ES mass and collision-induced dissociation (CID)
spectra were recorded on Q-TOF Ultima API and
xidation product Mass of GP Cmpd (MS/MS Fig4)
,19,19-2H3]A
4-17-
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O
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ol-3Q-TOF Global quadrupole (Q)-orthogonal accelera-
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on a Quattro Micro tandem quadruple instrument (all
Micromass/Waters, Manchester, UK). Each instru-
ment was fitted with a Z-spray nano-ES interface and
samples were electrosprayed from metal-coated bo-
rosilicate capillaries (Proxeon Biosystems A/S,
Odense, Denmark or New Objective, Woburn MA)
loaded with 1–5 L of oxosteroid GP hydrazone (1
ng/L) in methanol. On the Q-TOF and tandem
quadrupole instruments the capillary voltages used
were 1.75 and 1.2 kV, respectively. On the Q-TOF
instruments the cone-voltage was 100 V and the RF
lens voltage varied between 40 and 200 V. On the
tandem quadrupole the cone-voltage was varied be-
tween 30 and 60 V, with the RF lens voltage at 0.2 V.
With each instrument a counter current of dry nitro-
gen was used to aid solvent evaporation (cone gas,
40–100 L/h). With the Q-TOF instruments the colli-
sion cell located between the quadrupole and TOF
sections of the instrument was loaded with argon
giving a pressure reading on the near-by “analyzer”
Penning gauge of  5  105 mbar. Gas was main-
tained in the collision cell when recording both mass
and MS/MS spectra. For the recording of mass spec-
tra the potential offset on the collision cell was 10 V
(collision energy 10 eV for singly-charged ions). This
was varied between 10 and 50 V for the recording of
MS/MS spectra. The optimum value was established
to be 35 V for singly charged ions, while 17.5 V (35
eV) was used for doubly charged ions. The TOF
analyzer could be operated with either “V” (10,000
resolution, full width at half maximum height defi-
nition, FWHM) or “W” (17,500 resolution, FWHM)
optics. Most spectra were recorded with “W” optics.
When MS/MS spectra were recorded on the tandem
quadrupole, the hexapole collision cell was loaded
with Ar gas so as to give a pressure reading of 3 
103 mbar on the gas-cell Pirani gauge. The collision
energy was varied in the range of 10–50 eV. The
tandem quadrupole instrument has the additional
capacity to record both precursor ion and neutral loss
scans.
LC-MS and LC-MS/MS
LC-MS and LC-MS/MS chromatograms were re-
corded on the Q-TOF Global mass spectrometer
interfaced to a Cap-LC low flow-rate chromato-
graphy system (Micromass/Waters). Separation was
achieved on a C18 capillary column (PepMap C18
column 180 m  150 mm, 3 m, 100 A, Dionex,
Camberley, Surrey, UK), at a flow-rate set to 1
L/min. Mobile phase A was 50% methanol, 0.1%
formic acid, and mobile phase B consisted of 95%
methanol, 0.1% formic acid. Gradient elution was
performed starting at 5% B and rising to 60% B over
the first 10 min, increasing to 80% B during the next
5 min, and staying at 80% B for a final 10 min, before
returning to 5% B.Results
Oxidation of 3-Hydroxy-5 Sterols to 3-Oxo-4
Sterols
It was found necessary to modify the original procedure
of Brooks et al. [47] for the oxidation of 3-hydroxy-5
steroids, so as to make it compatible with the ES-MS
analysis of oxosterols and their GP hydrazones. Isopro-
panol is a good solvent for oxysterols, and cholesterol
oxidase was found to be still active when a solution of
oxysterol(s) in 50 L of isopropanol was added to 1 mL
of the enzyme in 50 mM phosphate buffer at pH 7. The
use of detergent to solubilize the enzyme and the
oxysterols was avoided, as it was found be difficult to
completely remove the detergent from the oxidation
products. After a suitable incubation period, our nor-
mal procedure was then to add methanol, GP hydrazine
and glacial acetic acid so as to obtain the derivative
directly without isolation of the ketone intermediate. In
preliminary experiments, however, the efficiency of the
oxidation reaction was evaluated by analysis of the
ketone formed before derivatization. This was achieved
by terminating the oxidation reaction by addition of
methanol to the reaction solution and extracting the
oxosterols on a C18 column using a recycling method.
By using the “recycling” method of solid-phase extrac-
tion it was possible to apply the oxosterols to the C18
column in a solution of high methanol content (50%
methanol). This was desirable to ensure that the oxo-
sterols were dissolved-in, rather than dispersed-in, so-
lution. The initial flow-through from the C18 column
was collected and diluted with water so as to decrease
its elutropic strength, the diluted flow-through was
then recycled through the column. Any oxosterols not
retained by the column following their initial applica-
tion were subsequently extracted by the column on
reapplication of the diluted flow-through. To monitor
the efficiency of the purification of oxosterols the entire
procedure was carried out using 14C-labeled choles-
terol. Radioactivity was found to be exclusively re-
tained on the column, and then completely eluted with
methanol.
The activity of the enzyme under the solution con-
ditions employed for the oxidation reaction was evalu-
ated with the use of 3-hydroxycholest-5-en-27-oic and
3-hydroxychol-5-en-24-oic acids. Both of these acids
will give [M  H] ions upon negative-ion ES ioniza-
tion, and hence their oxidation reactions can be moni-
tored by the decrease in [M  H] ion currents and the
complementary increase in ion current of the oxidation
products. Under the reaction conditions employed the
oxidation reactions were found to proceed to comple-
tion.
The choice of reaction time may have to be deter-
mined by the exact aim of the analysis. Compounds
having additional substituents in the A-ring and ste-
roids with no (C19) or a short (C21) side-chain react
much slower than cholesterol (see reference [48] for a
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tigated the effect of an extended reaction time on the
oxidation of cholesterol and found that minor products
with additional oxygens were formed when the oxida-
tion time exceeded 5 h, indicating that the cholest-4-en-
3-one underwent further oxidation.
Although not the focus of the current study, 5-
steroids with a 3-hydroxy group can be oxidized to
3-oxo-5-steroids. Using the above procedure latho-
sterol (3-hydroxy-5-cholest-7-ene, 5-C7-3-ol) was
successfully oxidized to its 3-oxo equivalent (5-C7-3-
one), as were a number of other 3-hydroxy-5-ste-
roids.
Derivatization of Oxosterols
The derivatization of oxosterols to GP hydrazones was
carried out essentially as described previously [38, 39].
However, it was found to be necessary to modify the
reaction conditions for the derivatization of oxosterols
with a labile 7-hydroxy-4-3-oxo structure which oth-
erwise underwent partial elimination of water with
formation of a dienone. This was achieved by allowing
the reaction to proceed at room temperature over night.
Under these milder conditions, the efficiency of the
derivatization reaction was monitored using 3-oxocho-
lest-4-en-27-oic (CA4-3-one) and 3-oxochol-4-en-24-oic
(BA4-3-one) acids, which in their underivatized forms
give [M  H] ion signals in ES spectra. After 12 h, the
signals for the underivatized acids were found to fall to
zero. It should be noted that for the majority of studies,
the derivatization reaction was carried out directly on
the products of the cholesterol oxidase reaction, without
any further purification or extraction.
Oxosteroids with structures other than 3-oxo-4
were successfully derivatized with the GP reagent. For
example, 5-cholestan-3-one (5-C-3-one), 17-acetoxy-
5-androstan-3-one (5-A-17-acetoxy-3-one), 20,21-
dihydroxy-5-pregnan-3-one (5-P-20,21-diol-3-one)
were converted to their 3-GP hydrazones; while 3-
hydroxy-5-cholestan-7-one (5-C-3-ol-7-one), 7-oxo-
cholesterol (C5-3-ol-7-one), 3-hydroxy-5-cholest-
8(14)-en-15-one (5-C8(14)-3-ol-15-one), a kind gift
from G. Schroepfer, and 3,17-dihydroxy-androst-5-
en-16-one (A5-3,17-16-one) were converted to 7-GP,
7-GP-5, 15-GP-D8(14), and 16-GP-5 hydrazones, re-
spectively. Additionally, cholesta-4,6-dien-3-one (C4,6-
3-one) was successfully converted to a 3-GP hydrazone,
and the plant sterol campesterol (C5-24-methyl-3-ol)
was successfully oxidized and derivatized to a 3-oxo-
4-3-GP hydrazone. Steroids containing two oxo groups
were converted to mono- and to a minor extent to
bis-GP derivatives. Depending on the position of the
second oxo group (i.e., the one not at C-3), the formation
of the bis-GP derivative was sometimes more pro-
nounced (e.g., 3,17-, 3,6- and 3,22-diones). Further stud-
ies are required to establish the reaction rates for
steroids with multiple oxo groups.Tandem Mass Spectrometry of Oxosterol GP
Hydrazones
Instrumental effects. Three tandem mass spectrometers
were used in this study each fitted with a nano-ES
source. Two of the instruments were of Q-TOF type, the
third was a tandem quadrupole. At a defined collision
energy, the three instruments gave similar but not
identical spectra. Some instrumental effects were noted,
in particular the transmission of low-mass fragments-
ions (200 Da) was found to be greater on the tandem
quadrupole than on the Q-TOF instruments. This is
illustrated in Figure 1, which shows 35 eV CID spectra
of C4-24-ol-3-one GP hydrazone (VI) recorded on the
tandem quadrupole (1a), Q-TOF Ultima API (1b), and
Q-TOF Global (1c) instruments. Note that in the spec-
trum recorded on the Q-TOF instruments (Figure 1b
and c) the m/z ranges 50–121 and 122–390 have been
magnified. The Q-TOF instruments also provide much
higher product-ion resolution than the tandem quadru-
pole instrument. Using the Q-TOF instruments and
employing “W” ion-optics, the product-ion resolution
was of the order of 17,500 (FWHM), this in combination
with the excellent stability of the instruments’ m/z range
allowed the routine acquisition of accurate mass data
(5–10 ppm).
In MS/MS spectra, 3-oxo-4 sterol GP hydrazones
give four main types of fragment ion: (i) those derived
from the GP hydrazone group, (ii) those resulting from
steroid ring and C-17 side-chain fragmentation and
which contain the hydrazone group, (iii) those which
are a result of the neutral loss of pyridine, carbon
monoxide and water from the molecular ion, and (iv)
those which correspond to small hydrocarbon ions
(Schemes 2 and 5). Conveniently, ions in groups (i)–(iii)
predominantly fall within distinct m/z ranges, i.e., (i)
50–121; (iia) 121–180; (iib) 180–390; and (iii) above 390,
and despite differences in absolute ion transmission
between the instruments, within defined m/z ranges the
instruments give normalized MS/MS spectra which are
quite similar, and allow a number of generalizations to
be made concerning the low-energy CID of oxosterol
GP hydrazones.
Group (i) fragment ions: GP hydrazone fragment ions. In
all of the MS/MS spectra of the 3-oxo-4 sterols studied a
series of fragment ions characteristic of the GP hydrazone
group is observed at m/z 80.05, 94.07, 109.08, 120.05 and
137.07. High-resolution accurate mass data shows that
these ions have the compositions C5H6N (1  H),
C5H5NCH3 (2  H), C5H5NCH2NH2 (4  H-CO),
C5H5NCHCO (3H), and C5H5NCH2CONH2 (4H),
respectively (Scheme 2). The peaks at 109 and 120 are in
fact doublets consisting of C5H5NCH2NH2/C8H13
(109.08/109.10) and C5H5NCHCO/C8H10N (120.05/
120.08), respectively, which are easily resolved on the
Q-TOF instrument operated in the “W”-mode. The frag-
ment-ion at m/z 80.05, abundant in the CID spectra re-
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target ion for precursor-ion scanning.
3-Oxo-4 Sterols: Compounds V–XVI (see Table 1)
Group (iia) fragment ions: Steroid skeleton fragment
ions. 3-Oxo-4 sterol GP hydrazones undergo frag-
mentation in the steroid-ring in an identical fashion to
other 3-oxo-4 steroid GP hydrazones [38]. In the ab-
sence of additional substituents on the ABC rings,
3-oxo-4 steroid GP hydrazones give two major series
of fragment ions at m/z 151.09 (*b1-12), 163.09 (*b2-CH2/
*b3-C2H4) and 177.10 (*b2); and at 123.09 (
#b1-12), 135.09
(#b2-CH2/
#b3-C2H4) and 149.11 (
#b2) (Figures 1 and 2)
Figure 1. MS/MS spectra of the [M] ion of
recorded on (a) tandem quadruple; (b) Q-TOF U
Collision energy 35 eV. Expanded views of the p
spectrum (c). In the spectra presented in (a), (b),
are 9:10:2, 9:10:1 and 6:10:2, respectively. In (b)
magnified by factors of 6 and 5, and 280 and 10, r
1–5 L of sample (1 ng/L) was loaded into the
acquisition.[38, 39]. The *b ion-series corresponds to B-ring frag-ment ions which have additionally lost the pyridine
ring of the GP hydrazone group, while the #b ion-series
corresponds to B-ring fragments where the pyridine
ring and CO groups have been lost (Scheme 2) [38, 39].
Griffiths et al. have shown that the *b1-12, *b2-CH2/*b3-
C2H4 and *b2 ions are formed via a [M -79]
 interme-
diate (which corresponds to the molecular-ion having
lost the pyridine ring), while the #b1-12,
#b2-CH2/
#b3-
C2H4 and
#b2 ions are formed via a [M-79-28]
 interme-
diate (Scheme 2) [38, 39]. Detailed studies using heavy-
isotope labels have shown the *b1-12 and
#b1-12 ions to
contain the A-ring plus C-19, but minus C-5; and the *b2
and #b2 ions to contain the A-ring plus C-19 and C-6
(Scheme 3) [38, 39]. The hypothesized *b2-CH2 and
-ol-3-one GP hydrazone (VI, m/z 534). Spectra
API, “W-mode”; (c) Q-TOF Global, “W-mode”.
at m/z 123 (d); 135 (e), 149 (f), and 163 (g) from
c) the ratio of fragment ions 123.09:135.09:149.11
(c), regions m/z 50–121 and 122–390 have been
tively. The y-axis represents relative abundance.
-ES capillary, and about 1 L consumed for theC4-24
ltima
eaks
and (
and
espec
nano#b2-CH2 fragments may more accurately be described as
of 3
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#b2-CH3-H2H ions. These ions
are suggested to contain the A-ring and C-6, but C-19
has been lost and replaced by an H-atom from C-7 or
the CD-rings, additionally the -H on C-6 has been
replaced by an H-atom from C-7 or the CD-rings [49].
The *b3-C2H4 and
#b3-C2H4 ions contain the A-ring plus
C-6 and C-7, but C-19 and C-10 have been lost as has a
H-atom, probably the -H from C-6 [52]. In 3-oxo-4 GP
hydrazones containing no further A or B ring substitu-
ents the *b3-C2H4 and *b2-CH3-H2H ions have identi-
cal elemental formula, as have the #b3-C2H4 and
#b2-
CH3-H2H ions [53]. Supporting evidence for the
structures of the B-ring fragment ions described above
(Scheme 3) has been obtained in the current study
where the *b1-12 and
#b1-12; *b2-CH2/*b3-C2H4 and
#b2-CH2/
#b3-C2H4; and *b2 and
#b2 fragment-ions from
[2,2,4,23-2H4]BA
4-3-one and [2,2,4,23-2H4]BA
4-3-one-24-
oylglycine GP hydrazones (XXIII and XXIV respec-
tively) were each found to be 3 Da heavier than the
equivalent ions from the monoisotopomers see Figure
S-3 in the Supplementary Material section (which can
be found in the electronic version of this article.). It
should be noted that the peaks at m/z 123, 135, 149, and
163 consisted of doublets (Figure 1d– g). This is evident
when spectra are recorded at high-resolution with the
Q-TOF instruments operated with “W” ion-optics. At
m/z 123.12, 135.12, 149.13, and 163.15 peaks correspond-
ing to C9H15, C10H15, C11H17 and C12H19 respectively,
are resolved from those at 123.09 (#b1-12, C7H11N2),
135.09 (#b2-CH2/
#b3-C2H4, C8H11N2), 149.11 (
#b2,
C9H13N2), and 163.09 (*b2-CH2/*b3-C2H4, C9H11N2O).
Addition of a 7-hydroxy group to the steroid skele-
ton drastically alters the pattern of B-ring fragment ions
Scheme 2. Fragmentation patternfor 3-oxo-4 sterol GP hydrazones (Figure 2). Fragmentions at m/z 135, 149, 163, and 177 are attenuated in the
spectra of 7-hydroxy-3-oxo-4 steroid GP hydrazones,
and accurate mass measurements at high-resolution
confirm that it is the #b2-CH2,
#b2, *b2-CH2, and *b2
components at these integer masses which are reduced
in abundance. In the spectrum of a 7-hydroxy-3-oxo-4
steroid GP hydrazone the #b3-C2H4, and *b3-C2H4 frag-
ment ions are expected to be shifted to m/z 151.09
(135.09  15.99, C8H11N2O) and 179.08 (163.09  15.99,
C9H11N2O2), respectively. Significantly, in the CID
spectrum of C4-7-ol-3-one GP hydrazone (V) (Figure
2e) the abundance of ions at m/z 151.09 and 179.08,
corresponding to ions of composition C8H11N2O and
C9H11N2O2, are enhanced in comparison to CID spectra
of C4-24-ol-3-one (VI) (Figure 2a and b), C4-25-ol-3-one
(VII) (Figure 2c), and C4-27-ol-3-one (VIII) (Figure 2d).
The elemental composition C8H11N2O (m/z 151.09) cor-
responds to a *b1-12 ion, a
#b3-C2H4 ion and also a
#b2-CH3-H  H  OH ion in C
4-7-ol-3-one GP hydra-
zone (V). The elemental composition C9H11N2O2 (m/z
179.08) corresponds to a *b3-C2H4 ion or a *b2-CH3-H 
H  OH. It is not surprising that the intensity of the
peaks corresponding to #b2 (m/z 149.11) and *b2 (m/z
177.10) are attenuated in the CID spectra of 7-hydroxy-
3-oxo-4 steroid GP hydrazones, as dehydration in the
B-ring would lead to the introduction of a double-bond
between C-6 and C-7 and resonance stabilization of the
positive-charge (Scheme 4). With the blocking of the #b2
and *b2 fragmentation channels, additional ion current
could then be channelled through to the #b1-12 (m/z
123.09) and *b1-12 (m/z 151.09) fragments.
In the CID spectra of 7-hydroxy-3-oxo-4 steroid GP
hydrazones (e.g., Figure 2e) the fragment ion at m/z
-oxo-4 steroid 3-GP hydrazones.179.08 corresponds to *b2-CH3-H  H  OH and to
350 GRIFFITHS ET AL. J Am Soc Mass Spectrom 2006, 17, 341–362Figure 2. MS/MS spectra of the [M] ion of GP hydrazones (a) C4-24-ol-3-one (VI, m/z 534.41); (b)
C4-24-ol-3-one from brain (VI, m/z 534.41); (c) C4-25-ol-3-one (VII, m/z 534.41); (d) C4-27-ol-3-one (VIII
m/z 534.41); (e) C4-7-ol-3-one (V, m/z 534.41); (f) C4-3,22-dione (X, m/z 532.39). The spectra in (a)–(f)
are of 3-GP hydrazones, that in (g) is of the [M]2 ion of C4-3,22-dione 3,22-bisGP hydrazone (XI, m/z
333.23). (h) Expanded views of the peaks at m/z 325 and 353 recorded at 17,500 (top panel) or 12,000
(central and bottom panel) resolution, FWHM definition. The upper panels in (h) show peaks from
C4-24-ol-3-one GP (VI); the central panels in (h) show peaks from C4-25-ol-3-one GP (VII); and the
bottom panels in (h) show peaks from C4-27-ol-3-one GP (VIII). In the spectra presented in (a)–(g) the
ratio of fragment ions 123.09:135.09:149.11 and 151.09:163.09:177.10 are 6:10:2 and 7:10:2 (a); 7:10:2 and
7:10:2 (b); 7:10:2 and 6:10:2 (c); 6:10:2 and 6:10:2 (d); 10:2:1 and 10:1:1 (e); 7:10:1 and 8:10:1 (f); 6:10:2 and
351J Am Soc Mass Spectrom 2006, 17, 341–362 ES-MS/MS OF OXYSTEROLSFigure 2 (continued). 10:10:2 (g). In (a)–(f) the m/z regions 50–121 and 122–390 have been magnified
by a factor of 280 and 10, respectively. In (g) the regions 50–121, 122–290, and 350–600 have been
magnified by a factor of 280, 10, and 10, respectively. The y-axis represents relative abundance. All
spectra recorded on the Q-TOF Global instrument in “W-mode” at a collision energy 35 eV. 1–5 L of
sample [1 ng/L for steroid standards and 10 g brain/L in (b)] was loaded into the nano-ES
capillary, and about 1 L consumed for the acquisition.
352 GRIFFITHS ET AL. J Am Soc Mass Spectrom 2006, 17, 341–362*b3-C2H4 ions. The *b2-CH3-H  H  OH ion is analo-
gous to the *b2-CH3-H  2H ion normally observed at
m/z 163.09 (Figure 2a– d), but where an OH-group
rather than H-atom is transferred from C-7 to the ion
(Scheme 3). The #b2-CH3-H  H  OH and
#b3-C2H4
ions have an identical elemental composition to a *b1-12
ion and also contribute to the enhanced intensity of the
ion at m/z 151.09. This was evident when CID spectra
were recorded of [M-107] ions from 7-hydroxy-3-
oxo-4 steroid GP hydrazones which can not fragment
to give *b-12 ions, but were observed to give abundant
fragment ions atm/z 151.09 corresponding to #b2-CH3-H
H  OH and #b3-C2H4 ions (data not shown).
Group (iib) fragment ions: Minor (low abundance) ring and
C-17 side-chain fragment ions. While the major cleav-
ages in the steroid ring system occur in the B-ring and
give abundant fragment ions, minor but important
fragment ions are generated by cleavages in the C- and
D-rings and in the C-17 side-chain giving ions of lower
abundance. In the CID spectra of 3-oxo-4 sterol GP
hydrazones *c2, *d1, *d2 *e-H, and/or *e  H fragment
ions are consistently observed at m/z 231.15
(C14H19N2O), 285.20 (C18H25N2O), 299.21 (C19H27N2O),
325.23 (C21H29N2O), and/or 327.24 (C21H31N2O) (e.g.,
cmpds VI-VIII, Figure 2a– d, Scheme 2). Incorporation
of a C-24 hydroxyl group results in the additional
appearance of #f-H and *f-H fragment ions at m/z 325.26
(C22H33N2) and 353.26 (C23H33N2O) (VI), (Figure 2a and
b). These fragment ions are absent or much weaker in
the spectra of C4-25-ol-3-one (VII) and C4-27-ol-3-one
(VIII) (Figure 2c, d, and h). The presence of the 25-
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Scheme 3. Structures of b-type fragment ions. For simplicity the
hydrazone has been drawn as a linear chain; alternatively the
Y-group can be bound to C-4 with charge located on the A-ring. In
*b-type ions Y  COCH2, in
#b-type ions Y  CH2. The structures
in brackets are analogous to those suggested to correspond to
fragment ions of protonated testosterone [52].hydroxyl group in C4-25-ol-3-one (VII) facilitates frag-mentation between C-23 and C-24 with the formation of
comparatively abundant fragment ions at 353.30 (#h-H,
C24H37N2) and 381.29 (*h-H, C25H37N2O) (Figure 2c).
Incorporation of two hydroxyl groups in the C-17
side-chain as in C4-20R,22R-diol-3-one GP hydrazone
(XII) results in enhanced abundance of fragment ions at
299.25 (C20H31N2), 327.24 (C21H31N2O), and 353.26
(C23H33N2O) corresponding to
#eH, *eH and *fH-
H2O respectively (Figure 3b). Altering the steroid ring
system by introduction of a labile 7-hydroxy group
results in the formation of *c2-H2O, *c2  2H-H2O,
*e-H-H2O, and/or *e  H-H2O fragment ions at m/z
229.13 (C14H17N2O), 231.15 (C14H19N2O), 323.21
(C21H27N2O), and/or 325.23 (C21H29N2O), respectively,
(Scheme 4, Figure 2e, Figure 3a, and Supplementary
Material Figure S-1). The combined presence of 7- and
25-hydroxyl groups on the C4-3-one template (XIII,
XIV) results in enhanced intensity of a fragment ion at
341.22 (C21H29N2O2) corresponding to *e-H, particu-
larly in spectra of the 7 isomer (XIV). In contrast, the
7 isomer shows enhanced abundance of an ion at
203.15 (#c2  2H-H2O, C13H19N2) and at 231.15 (*c2 
2H-H2O, C14H19N2O) (XIII). Similarly, in spectra of
C4-7,27-diol-3-one (XV), the fragment ions at 203.15
and 231.15 are comparatively abundant, but fragment
ions are not observed at 341.22.
Group (iii) fragment ions: GP hydrazone neutral-loss frag-
ment ions. Each of the 3-oxo-4 sterol GP hydrazones
investigated in the present study give [M-79] and
[M-107] fragment ions which are formed by the neu-
tral-loss of pyridine; and pyridine plus CO, respectively
(Scheme 2). Similar fragment ions were observed in the
MS/MS spectra of other 3-oxo-4 steroid GP hydra-
zones [38, 39]. The added presence of hydroxyl groups
on the cholest-4-en-3-one skeleton results in the addi-
tional formation of [M-79-(n18)] and [M-107-(n18)]
ions, where n is the number of additional hydroxyl
groups. The relative intensities of these ions depend on
the location of the hydroxyl groups. From the MS/MS
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Scheme 4. Fragmentation pattern of 7-hydroxy-3-oxo-4 steroid
GP hydrazone.
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hydrazones, the order of hydroxyl-group lability giving
[M-79-18] and [M-107-18] ions at 437.35 and 409.36
was determined to be 25-OH	24-OH 7 -OH	27-OH
(Figure 2). This difference in the ease of dehydration
between sterol isomers aids in their differentiation
when not present in a mixture.
The hydroxyl groups at 20R and 22R are surprisingly
stable, and in the CID spectrum of C4-20R,22R-diol-3-
one GP hydrazone (XII) the [M-79-(n18)] at 453.35 and
435.34; and [M-107-(n18)] ions at 425.35 and 407.34 are
Figure 3. MS/MS spectra of the [M] ion of
550.40); (b) C4-20R,22R-diol-3-one (XII, 550.40);
(IV, m/z 544.43). In the MS/MS spectra the rat
163.09:177.10 are 10:1:1 and 10:1:1 (a); 7:10:1 and
In (a), (c), and (d) the m/z regions 50–121 and 12
respectively, while in (b) by a factor of 54 a
abundance. All spectra recorded on the Q-TOF G
35 eV. 1–5 L of sample (1 ng/L) was loaded i
for the acquisition.present at less than 2% of the intensity of the [M-79]ion (Figure 3b). In contrast, the hydroxyl group on C-25
is labile, this is evident in the CID spectra of C4-7,25-
diol-3-one (XIV) and C4-7,25-diol-3-one (XIII) GP hy-
drazones (see Supplementary Material Figure S-1),
where strong/medium intensity [M-79-18] fragment
ions are observed at m/z 453.35 (RA 55%, 20%), as are
weaker satellite peaks corresponding to [M-79-(2 
18)] at m/z 435.34 (RA 5%, 5%), and [M-107-18] at m/z
425.35 (RA 5%, 5%). Peaks are also observed at m/z
407.34 from the C4-7,25-diol-3-one isomers, correspond-
ing to fragments [M-107-(2  18)], but these are of low
ydrazones of (a) C4-7,27-diol-3-one (XV, m/z
4-3-one (I, m/z 518.41); (d) C4,22-24-ethyl-3-one
fragment ions 123.09:135.09:149.11 and 151.09:
:1 (b); 6:10:2 and 6:10:2 (c); 6:10:1 and 8:10:1 (d).
have been magnified by a factor of 280 and 10,
0, respectively. The y-axis represents relative
l instrument in “W-mode” at a collision energy
e nano-ES capillary, and about 1 L consumedGP h
(c) C
io of
8:10
2–390
nd 1
loba
nto thintensity (RA 2%, 2%). In comparison, when the side-
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C4-7,27-diol-3-one GP hydrazone (XV), [M-79-18]
and [M-107-18] ions are observed to give compara-
tively weak peaks (m/z 453.35, 5%; m/z 425.35, RA)
(Figure 3a).
Bile Acids, Compounds XVII–XXV: And 22-
Oxocholesterols, Compounds X–XI (see Table 1)
Cholest-5-en-27-oic acids are intermediates in the con-
version of cholesterol to bile acids, and 3-hydroxycho-
lest-5-en-27-oic acid and its 7-hydroxylated product
3,7-dihydroxycholest-5-en-27-oic acid are quantita-
tively dominating unconjugated bile acids in the human
circulation [1, 3]. After oxidation of these compounds
with cholesterol oxidase and derivatization with GP
hydrazine, the resulting 3-oxo-4 acids undergo CID
reactions to give fragment ions in accord with their
structural features as discussed above (see Supplemen-
tary Material Figure S-2). For example, CID of
[16,16,17(or 20),22,22,23,23-2H7]CA
4-3-one GP hydra-
zone (XVII) gives the #b-type fragment ions #b1-12 (m/z
123.09), #b2-CH2/
#b3-C2H4 (m/z 135.09) and
#b2 (m/z
149.11); and the *b-type fragment ions *b1-12 (m/z
151.09), *b2-CH2/*b3-C2H4 (m/z 163.09) and *b2 (m/z
177.10): while in CID spectra of 7-hydroxylated acids
(and methyl esters), B-ring fragment ion peaks #b2-CH2
(m/z 135.09), #b2 (m/z 149.11), *b2-CH2 (m/z 163.09) and
*b2 (m/z 177.10) are attenuated. The presence of a
7-hydroxy group on the steroid skeleton results in
enhanced intensity of the peak at m/z 151.09 corre-
sponding to #b3-C2H4 and *b1-12, and also m/z 179.08
corresponding to *b3-C2H4.
Ions of minor abundance but of structural importance
are generated by cleavages in the C- and D-rings and the
C-17 side-chain. In the CID spectrum of [16,16,17(or
20),22,22,23,23-2H7]CA
4-3-one GP hydrazone (XVII) frag-
ment ions characteristic of 3-oxo-4 sterols are observed at
m/z 231.15, 285.20, 299.21 corresponding to *c2, *d1, and *d2
cleavages. A cluster of ions from 327.24 (C21H27D2N2O,
[2H2]*e-H) to 330.26 (C21H28D3N2O, [
2H3]*e  H) is also
seen corresponding to *e-H and *eH fragment ion with
differing degrees of deuteration. As was the case with the
oxosterols discussed above, altering the steroid ring sys-
tem by introduction of a labile 7-hydroxy group results
in the formation of *c2-H2O, and *c2  2H-H2O, frag-
ment ions at m/z 229.13, and 231.15; and a cluster of
ions corresponding to *e-H-H2O and *e  H-H2O be-
tween 325.22 (C21H25D2N2O, [
2H2]*e-H-H2O] and 328.25
(C21H26D3N2O, [
2H3]*e  H-H2O). As in the spectrum of
C4-7,27-diol-3-one fragment ions are also observed at
203.15 (#c2  2H-H2O).
As in the spectra of oxysterol GP hydrazones, [M-79-
18] and [M-107-18] ions are observed in the spectra of
the 27-oic acids. The presence of these ions at m/z 458.38
(RA 2%) and 430.38 (RA 2%) in the spectrum of
[16,16,17(or 20),22,22,23,23-2H7]CA
4-3-one (XVII) shows
that water can be eliminated from the C-27 acid group. Inthe spectra of the 7-hydroxy acids the intensity of the
[M-79-18] and [M-107-18] ions at 474.37 (RA 5%) and
446.38 (RA 5%) are enhanced, and additional minor inten-
sity peaks at 456.36 (RA 2%) and 428.37 (RA 2%)
corresponding to [M-79-(2  18)] and [M-107-(2  18)]
are observed. Predictably, the spectra of the 24-methyl
esters of the [16,16,17(or 20),22,22,23,23-2H7]CA
4-7-ol-3-
one GP hydrazones (XX and XXI) show [M-79-18],
[M-79-32], and [M-79-18-32] at m/z 488.39 (RA 5%),
474.37 (RA 1%), and 456.36 (RA 1%); and [M-107-18],
[M-107-32], and [M-107-18-32] at m/z 460.39 (RA 2%)
446.38 (RA 1%) and 428.37 (RA 2%), respectively.
The C24 bile acid 3-hydroxychol-5-en-24-oic acid, its
[2,2,4,4,23-2H5] isotopomer and glycine conjugate, and
also 3,7-dihydroxychol-5-en-24-oic acid, were oxi-
dized with cholesterol oxidase, reacted with GP hydr-
azine, and analyzed by ES mass spectrometry. Oxida-
tion of these bile acids with cholesterol oxidase results
in conversion of the 3-hydroxyl group to a ketone, and
movement of the 5(6) double-bond to 4(5). In this
translocation one of the deuterium atoms on C-4 of the
deuterated isotopomers is lost to give a mass increase
overall of 4 Da (i.e., [2,2,4,23-2H4]) compared to the
unlabeled isotopomer (other isotopomers present in-
clude [2H3] and [
2H5], and to a lesser extent [
2H1] and
[2H6]). The CID spectrum of BA
4-3-one (XXII) showed
the classical fragmentation pattern of a 3-oxo-4 GP
hydrazone. The interpretation of this CID spectrum was
then confirmed by recording the analogous spectrum of
the [2,2,4,23-2H4] isotopomer (XXIII) (see Supplemen-
tary Material Figure S-3). As anticipated #b1-12,
#b2-
CH2/
#b2-C2H4, and
#b2 ions were shifted up in mass by
3 Da, as were *b1-12, *b2-CH2/*b2-C2H4 and *b2 ions
(Scheme 3). Notably, *c2 was also observed shifted up
by 3 Da fromm/z 231.15 to 234.17. The glycine conjugate
of the [2,2,4,23-2H4] isotopomer gave a similar series of
fragment ions. Due to the inhomogeneity of isoto-
pomers of [2H4]BA
4-3-one and its glycine conjugate,
many fragments were observed as 2 and 3 Da
doublets. Incorporation of a 7-hydroxy group in the
bile acid structure, results in a change in the pattern of
B-ring fragments. As was the case with other 7-hy-
droxy-3-oxo-4-GP hydrazones, in the CID spectrum of
BA4-7-ol-3-one (XXV) the B-ring fragment ion peaks
#b2-CH2 (m/z 135.09),
#b2 (m/z 149.11), *b2-CH2 (m/z
163.09) and *b2 (m/z 177.10) are attenuated, while peaks
at 123.09 (#b1-12), 151.09 (
#b3-C2H4/*b1-12) and 179.08
(*b3-C2H4) are accentuated. Again the presence of the
labile 7-hydroxy group had the effect of enhancing the
intensity of [M-79-18] and [M-107-18] ions.
When 22-oxocholesterol was oxidized with choles-
terol oxidase and treated with GP hydrazine, two major
peaks were observed in the ES mass spectrum at m/z
532.39 and 333.23. The peak at 532.39 corresponds to the
mono-GP hydrazone (X) and that at 333.23 to the
doubly charged bis-GP hydrazone (XI). CID of the
mono-GP hydrazone gives the expected series of ring
fragments for a 3-oxo-4 3-GP hydrazone, i.e., #b1-12
(123.09), #b2-CH2/
#b3-C2H4 (135.09),
#b2 (149.11), *b1-12
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(231.15); but with enhanced abundance of fragment ions
at 282.22 (C20H28N), 297.23 (C20H29N2), 312.27
(C22H34N), 325.23 (C21H29N2O), 327.28 (C22H35N2), and
355.27 (C23H35N2O) corresponding to
#e-H-NH, #e-H, #f
H-NH, *e-H, #fH and *fH or #gH, respectively
(Figure 2f). Both *f  H and #g  H fragments have the
elemental composition C23H35N2O. The absence of an
ion at m/z 355.27 in the CID spectrum of the [M-107]
ion, but the presence of an ion at m/z 327.28 correspond-
ing to the #f  H fragment in the spectrum (data not
shown), strongly suggests that the ion of m/z 355.27 in
the spectrum of the [M] ion corresponds to a *f  H
fragment. In the low mass range of the spectrum, the
usual pattern of fragment ions at m/z 80.05, 94.07,
108.08, 109.08, 120.05/120.08 and 137.07 is distorted by
the presence of ions at m/z 81.07 and 99.08. These ions
correspond to hydrocarbon fragments with chemical
formulas C6H9, and C6H11O formed by cleavage of the
C-20–C-22 bond  to the carbonyl group at C-22. The
C6H9 (F-H2O) fragment is probably derived by water
loss from C6H11O (F) (Scheme 5). The structural signif-
icance of these low-mass fragment ions observed in the
CID spectrum of C4-3,22-dione 3-GP hydrazone encour-
aged us to reinspect the low mass regions of our spectra
(see below).
In the CID spectrum of the [M]2 ion of the bis-GP
hydrazone (XI) the low mass range is also different to
that normally observed for a 3-oxo-4 GP hydrazone, in
that additional peaks are observed at m/z 91.05 (C7H7)
and 112.11 (C7H14N). The characteristic
#b1-12 (123.09),
#b2-CH2/
#b3-C2H4 (135.09), *b1-12 (151.09), and *b2-
CH2/*b2-C2H4 (163.09) ions are observed, but are of
minor abundance. The presence of the substituent on
C-22 facilitates cleavage of the C-20–C-22 bond with the
formation of a *f-H (353.26) fragment. The spectrum is
dominated by fragment ions formed by losses from the
GP hydrazone group giving doubly charged ions at m/z
293.71 ([M-79]2, C36H53N5O2), 279.71 ([M-107]
2,
C35H53N5O), 254.19 ([M-(79  2)]
2, C31H48N4O2) and
240.19 ([M-79-107]2, C30H40N4O). Complementary sin-
gly charged ions are observed at 586.41 ([M-80],
C36H52N5O2) and 507.37 ([M-79-80]
, C31H47N4O2), and
additional singly charged fragments are observed at
544.40 ([M-122], C34H50N5O), 543.41 ([M-107-16]
,
C35H51N4O), 516.40 ([M-150]
, C34H50N3O), 465.36 ([M-
107-94], C29H45N4O), 464.36 (C30H46N3O), and 437.35
([M-79-150], C29H45N2O).
Group (iv) fragment ions: Hydrocarbon ions. To aid the
interpretation of the hydrocarbon fragment ion pattern
formed by 3-oxo-4 sterol GP hydrazones it is advanta-
geous to consider the CID spectra of the simplest C27
steroid, i.e., C4-3-one GP hydrazone (I) (Figure 3c), and of
a simple C19 steroid, i.e., A
4-17-ol-3-one GP hydrazone
(XXVI) (spectrum not shown). Peaks at m/z 81.07 (C6H9),
93.07 (C7H9), 95.09 (C7H11), 105.07 (C8H9), 107.09 (C8H11),
109.10 (C8H13), and 119.09 (C9H11) are observed in both
spectra indicating that they are derived from the steroidring system. There is enhanced intensity at m/z 95.09,
107.09 and 109.10 and an additional peak at 111.12 (C8H15)
in the spectrum of C4-3-one GP hydrazone demonstrating
that these peaks are additionally derived from the side-
chain. At higher mass, fragment ions are observed at
201.16 (C15H21), and 253.20 (C19H25) in the spectrum of
A4-17-ol-3-one corresponding to the doubly unsaturated
ABC ring system, and the triply unsaturated steroid
ABCD-ring system plus C-18 and C-19, respectively,
(Scheme 5). These ions are present in the spectrum of
C4-3-one GP hydrazone, but are of low abundance, in-
stead a fragment ion is observed at 367.34 (C27H43) corre-
sponding to the cholestane skeleton with two double
bonds. Compared with this template, the CID spectra of
3-oxo-4 sterol GP hydrazones show many similarities.
The isomers of monohydroxylated C4-3-one GP hydra-
zone (V–IX) show the same pattern of lowmass fragments
as C4-3-one GP hydrazone (Figure 2a– e). At higher mass
peaks at m/z 199.15 (C15H19), 253.20 (C19H25) and 365.32
(C27H41) are observed consistently; while a peak at m/z
383.33 (C27H43O) corresponding to doubly unsaturated
cholestanol is observed in the spectra of the 7-hydroxy-
and 27-hydroxy-isomers (Scheme 5). The 7-hydroxy iso-
mer additionally gives fragment ions at m/z 247.24
(C18H31, B3-H), and 287.27 (C21H35, B1  12  H-H2O)
(Scheme 5). These ions are complementary to b3-type and
b1-12 type fragments respectively, and their formation is
encouraged by the presence of the 7-hydroxyl group.
The dihydroxylated versions of C4-3-one carrying hy-
droxyl groups in the side-chain and at C-7 give essentially
the same pattern of low mass fragment ions as their
monohydroxy analogs, this is also true in the higher mass
range, however, the peak at m/z 365.32 is now shifted to
363.31 (C27H39), that at 383.33 to 381.32 (C27H41O), and
that at 247.24 to 245.23 (C18H29, B3-H-H2O), while the peak
at m/z 287.27 is no longer observed (Figure 3a, and
Supplementary Material Figure S-1). Incorporation of two
hydroxyl groups on the side-chain as in C4-20R,22R-diol-
3-one (XII), has a major effect on the pattern of low mass
hydrocarbon fragment ions (Figure 3b). In the low mass
range, the dominant fragment ion is now at 109.10
(C8H13); this is more intense than the fragment ions at m/z
94.07 (2H, C6H8N), 108.08 (C7H10N), and 120.05 (3-H,
C7H6NO), which normally dominate this region of the
spectrum. The ion at m/z 109.10 (C8H13) corresponds to a
doubly unsaturated side-chain fragment formed by cleav-
age of the C-17–C-20 bond  to the C-20 hydroxyl group,
i.e., E-(2xH2O). In the higher mass range essentially only
the hydrocarbon fragment ion at 253.20 (C19H25) is
observed.
As discussed above, the low mass pattern of fragment
ions is distorted in the CID spectra of C4-3,22-dione 3-GP
hydrazone (X) (Figure 2f). Ions at m/z 81.07 (C6H9) and
99.08 (C6H11O) corresponding to fragments formed by
cleavage of the C-20–C-22 bond  to the carbonyl group
now dominate this region of the spectrum. The C6H9
fragment is probably derived by water loss from C6H11O.
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Modified Cholesterols: Compounds I–IV
(see Table 1)
During the analysis of oxysterols from biological
sources possibly the oxysterol fractions may be contam-
inated with cholesterol, its precursors, and possibly by
plant sterols present from the diet. We have thus
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Scheme 5. Hydrocarbon fragment ions form
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reduction in fragment ion mass by 2.02 Da.oxidized and derivatized cholesterol, its precursor des-mosterol (C5,24-3-ol), and the plant sterols stigmasterol
(24-ethyl-cholesta-5,22-dien-3-ol, C5,22-24-ethyl-3-
ol), and sitosterol (24-ethyl-cholest-5-en-3-ol, C5-24-
ethyl-3-ol) and analyzed their GP hydrazones.
Desmosterol is a precursor in the de novo synthesis
of brain cholesterol [54]. When oxidized with choles-
terol oxidase and derivatized with GP hydrazine, CID
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steroids (see Supplementary Material Figure S-4). How-
ever, peaks at 353.26 (C23H33N2O) and 355.27
(C23H35N2O) corresponding to *f-H and *f  H; and
325.26 (C22H33N2) and 327.28 (C22H35N2) correspond to
#f-H and #fH, are of elevated intensity. These ions are
formed by cleavage of the bond between C-20 and C-22
with hydrogen transfer from (f-H), and to (f  H), the
ionic fragment.
The level of the plant sterol sitosterol in serum is
often used as a marker for cholesterol absorption. Sterol
esters, including those of sitosterol and stigmasterol, are
present in phytosterol ester enriched low-fat food prod-
ucts, and their consumption has been shown to reduce
serum total and LDL cholesterol levels [55, 56]. Con-
versely, phytosterol levels in plasma become elevated
upon consumption of these foods [55]. The CID spectra
of C4-24-ethyl-3-one (III) and C4,22-24-ethyl-3-one
(IV) GP hydrazones showed the common features of
3-oxo-4 GP hydrazones (Figure 3d and Supplementary
Material Figure S-4). The spectrum of C4-24-ethyl-3-
one (III) was very similar to that of C4-3-one (I),
however, the peak at 367.34 (C27H43) in the spectrum of
C4-3-one, and corresponding to the doubly unsaturated
cholestane skeleton (Scheme 5), was shifted to 395.37
(C29H47) in the spectrum of the 24 analog. The pres-
ence of the C-22 – C-23 double-bond in C4,22-24-ethyl-
3-one (IV) is reflected in the low-mass region of the
MS/MS spectrum where the intensity of the ion at m/z
83.09 (C6H11) is greatly enhanced (Figure 3d). This ion is
formed by cleavage of the C-23–C-24 bond  to the
C-22–C-23 double-bond. The C-22–C-23 double-bond
also has an effect on other side-chain fragmentations.
As in the spectrum of C4-20R,22R-diol-3-one GP hydra-
zone (XII) (Figure 3b), there is enhanced abundance of
Figure 4. Mass spectrum of the oxidized and d
of sample loaded into the ES-capillary correspo
Q-TOF Global instrument in “W-mode”. The yfragment ions at m/z 284.24 (C20H30N,
#e  H-NH),299.25 (C20H31N2,
#e  H), and 327.24 (C21H31N2O, *e 
H), each formed as a result of cleavage of the C-17–C-20
bond, and in the case of C4,22-24-ethyl-3-one (IV),  to
the double-bond. It is interesting to note that a similar
triad of fragment ions is observed in the spectrum of
C4-3,22-dione 3-GP hydrazone (X) but shift to lower
mass by 2 Da (Figure 2f). The CID spectrum of C4,22-
24-ethyl-3-one is further characterized by peaks at
353.30 (C24H37N2,
#hH), and 381.29 (C25H37N2O, *h
H) both formed as a result of cleavage of the C-23–C-24
bond.
Oxysterols in Brain
To evaluate the analytical method described above the
oxysterol content of rat brain was investigated. Oxys-
terols in rat brain were extracted [36, 37], oxidized with
cholesterol oxidase, and derivatized to GP hydrazones.
The method has yet to be fully optimized and further
details of the extraction procedure will be published
when appropriate. Shown in Figure 4 is the ES mass
spectrum of the oxidized and derivatized oxysterol
fraction of rat brain. The amount of sample loaded into
the ES-capillary corresponded to 40 g of brain. A
major peak is observed at m/z 534.41, which corre-
sponds to the m/z of the [M] ion of a monohydroxy-
3-oxo-4 C27 steroid GP hydrazone. MS/MS of the ion
at m/z 534.41 gave the spectrum shown in Figure 2b. The
low-mass pattern of fragments at m/z 80.05, 94.07,
108.08, 109.08, 120.05, and 137.07, and the high-mass
pattern at 455.36 ([M-79]) and 427.37 ([M-107]), con-
firmed that the precursor ion corresponded to a GP
hydrazone. The fragment ion pattern 123.09 (#b1-12),
135.09 (#b2-CH2/
#b3-C2H4), 149.11 (
#b2), 151.09 (*b1-12),
163.09 (*b2-CH2/*b2-C2H4), and 177.10 (b2) are indica-
tized oxysterol fraction of rat brain. The amount
to 40 g of brain. Spectrum recorded on the
epresents relative abundance.eriva
ndedtive of a 3-oxo-4 GP hydrazone unsubstituted at posi-
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observed at 231.15 (*c2), 285.20 (*d1), 325.23 (*e-H),
325.26 (#f-H), 327.24 (*e  H), and especially at 353.26
(*f-H), which are consistent with a 24-hydroxycholest-
4-en-3-one GP hydrazone (VI) structure. 24-Hydroxy-
cholest-4-en-3-one is the product of cholesterol oxidase
mediated oxidation of 24-hydroxycholesterol. The iden-
tification of 24-hydroxycholesterol in brain is in agree-
ment with the work of Smith and colleagues who
showed in 1973 that 24-hydroxycholesterol is the major
oxysterol in brain [57], and of Björkhem and colleagues
who have shown that in rat about 70% of the 24S-
hydroxycholesterol in plasma is of cerebral origin [58].
Exact mass measurements made in the ES mass spec-
trum shown in Figure 4 suggest the presence of a
second 3-oxo-4-steroid GP hydrazone at m/z 550.40. A
mass of 550.40 Da corresponds to a dihydroxy-3-oxo-4
C27 steroid GP hydrazone, and CID of the ion at m/z
550.40 gives a spectrum indicative of a dihydroxy-3-
oxo-4 C27 steroid GP hydrazone, with probably the
two hydroxyl groups on the C-17 side-chain (see Sup-
plementary Material Figure S-1f), but not a 20,22-diol.
Many peaks in the CID spectrum of m/z 550.40 are not
easily explained by a single dihydroxy-3-oxo-4 C27
steroid GP hydrazone structure, and it seems likely that
more than one compound (isomer) is being subjected to
MS/MS. It should be noted, that to obtain sufficient
precursor-ion current the resolution of the quadrupole
was reduced so as to allow transmission of an m/z
window of about 2 units. Significantly, the fragment
ions at m/z 120.05 (3-H), and 137.07 ( 4  H) are more
abundant than is normally the case with 3-oxo-4-
steroids, and additional fragment ions are observed at
167.12 and 181.13 of unknown origin.
Zhang et al. have demonstrated the conversion of
24-hydroxycholesterol to 24,25-dihydroxycholesterol in
cultures of fetal rat astrocytes [59]. In the same study,
they showed that 24-hydroxycholesterol is not 7-hy-
droxylated in these cultures, and it has subsequently
been confirmed that CYP7B1 does not 7-hydroxylate
24-hydroxycholesterol. The possibility exists that the
24,25 diol is cleaved by oxidation into a C-24 acid. In
brain this would lead to the cholenoic acid that can be
7-hydroxylated [60]. More recently, Mast et al. [61] have
shown that CYP46A1, the enzyme responsible for 24S-
hydroxylation of cholesterol in brain, can further me-
tabolize 24S-hydroxycholesterol to 24,25- and 24,27-
dihydroxycholesterol in cell cultures transfected with
human CYP46A1 cDNA and in an vitro reconstituted
system with recombinant enzyme. In vivo studies on
the metabolism of 24-hydroxycholesterol in humans
have shown that 27-hydroxylation, formation of bile
acids and double conjugation are the main pathways of
metabolism in man [25].
The apparent inhomogeneity of the precursor ion at
m/z 550 emphasizes the importance of the incorporation
of a LC step before mass analysis so as to resolve
isomeric compounds in the time domain. Procedures to
analyze oxysterol GP hydrazones by capillary-LC-MS/MS using the Q-TOF instruments and the triple
quadrupole are currently being studied in our labora-
tories, and we show only preliminary data here.
Using the C18 capillary column with gradient elution
we are able to separate the reference monohydroxy-3-
oxo-4 C27 steroid GP hydrazones. When the brain
sample was injected onto the column following oxida-
tion and derivatization, only one chromatographic peak
was observed to corresponding to a monohydroxy-3-
oxo-4 C27 steroid GP hydrazone (M
, m/z 534.41)
(Figure 5a). The retention time for this compound was
identical to that of reference C4-24S-ol-3-one GP hydra-
zone (VI, 21.04 min) and it gave an MS/MS spectrum
consistent with this structure (cf Figure 5a inset, Figure
2a and b). Dihydroxy-3-oxo-4 C27 steroid GP hydra-
zones give an M ion at m/z 550.40. A reconstructed ion
chromatogram (RIC) for this ion in the brain sample
gave at least four chromatographic peaks (Figure 5b),
one of which gave an MS/MS spectrum of a dihydroxy-
3-oxo-4 C27 steroid GP hydrazones where both hy-
droxyl groups are probably on the C-17 side-chain
(Figure 5b).
Discussion
Fragmentation of 3-Oxo-4 Steroids
and Their Cationic Derivatives
The fragmentation reactions of 3-oxo-4 steroids, their
3-oxime, and Girard hydrazone derivatives have previ-
ously been investigated [38 – 40, 49, 50, 52]. There is
general agreement as to the structure of the b1-12 and b2
type ions, but some debate as to the structure of the
b2-CH2 type ions [53]. The use of deuterium labeled
steroids in this current study provide further evidence
for the b1-12 type ions to consist of the steroid A-ring
plus C-19 but minus C-5; and the b2 type ions to consist
of the A ring, C-6 and C-19 (Scheme 3). The structure of
the b2-CH2 type ions is less clear-cut. After performing
detailed stable-isotope labeling studies Liu et al. [49]
proposed that these ions contain the A-ring and C-6, but
that C-19 has been lost and replaced by H-atom from
C-7 or the CD-rings. In addition, the 6-H has been
replaced by an H-atom from C-7 or the CD-rings. A
better description for these types of ions is thus b2-
CH3-H 2H (Scheme 3). In contrast to this explanation,
Williams et al. [52] in their study of testosterone and
hydroxylated versions thereof proposed that Liu’s b2-
CH2 ions consist of the A-ring, plus C-6 and C-7 but
minus C-10 and C-19 and a H-atom from C-6. (Scheme
3), and are thus better described as b3-C2H4 ions. In the
current study, when a 7-hydroxyl group was incorpo-
rated into the 3-oxo-4 structure, GP hydrazone frag-
ment ions were observed at m/z 135.09 and 163.09,
corresponding to ions with the elemental composition
C8H11N2 (
#b2-CH2) and C9H11N2O (*b2-CH2), respec-
tively, but at reduced abundance (Figure 2). According
to Liu’s structure, such ions would be better described
as b2-CH3-H  2H type ions. Williams’ b3-C2H4 type
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but rather 151.09 (C8H11N2O) and 179.08 (C9H11N2O2),
respectively. Thus, the observation of fragment ions at
m/z 135.09 and 163.09 in the spectra of 7-hydroxy-3-
oxo-4 steroids indicates that a reaction channel exists
for the formation of ions with Liu’s b2-CH3-H  2H
structure (Figure 2e, Scheme 3). The presence of a
7-hydroxyl group on the steroid skeleton does results
also in the formation of fragment ions at m/z 179.08,
these ions could be formed by cleavage between C-6
and C-7 with the accompanying loss of C-19 and 6-H,
but with the gain of a H-atom from the CD ring and an
OH group from C-7, i.e., *b2-CH3-H  H  OH (Figure
2e, Scheme 3). Alternatively, the ion at m/z 179.08 could
simply be of the structure *b3-C2H4 as suggested by
Williams et al. The equivalent #b2-CH3-H  H  OH
and #b3-C2H4 ions appear at m/z 151.09, as do *b1-12
ions. The dominant b-type ions in the CID spectra of
7-hydroxy-3-oxo-4 steroid GP hydrazones appear at
m/z 123.09 (C7H11N2,
#b1-12) and 151.09 (C8H11N2O,
*b1-12 or 
#b2-CH3-H  H  OH and 
#b3-C2H4) (Figures
2e, 3a, and Supplementary Material Figure S-1). This
prominence of b1-12 type ions can be explained by the
lability of the C-7 hydroxyl group and its propensity to
eliminate as water and generate a double-bond between
C-6 and C-7, thereby attenuating alternative b-type
fragmentation channels. The overriding abundance of
the ion at m/z 151.09 is probably a consequence of the
fact that different fragment ions, i.e., #b2-CH3-H  H 
Figure 5. (a) RICs for a reference mixture of C4-
trace); and C4-24S-ol-3-one GP (red upper t
derivatization. The inset shows the MS/MS spe
brain. (b) RIC for m/z 550.40 from the brain sam
shows the MS/MS spectrum of m/z 550.40 elutin
Global in the “V-mode”.OH, #b3-C2H4, and *b1-12, each has an identical elemen-tal composition and a mass of 151.09 and each contrib-
utes to the ion current giving this peak.
In summary, the results of the current study indicate
that Liu’s b2-CH3-H  2H type ions can be formed, but
do not allow the differentiation of b3-C2H4 from b2-
CH3-H  2H in 3-oxo-
4 steroids without a hydroxyl
group at C-7; or b3-C2H4 from b2-CH3-H  H  OH in
7-hydroxy-3-oxo-4 steroids ions. To elucidate further
the structure of these ions, 3-oxo-4 steroids labeled
with 13C at C-7 or C-10 should be analyzed.
While the B-ring fragment ions are the dominant cleav-
age products of the steroid skeleton, fragment ions impor-
tant in the structural identification of 3-oxo-4 sterol GP
hydrazones are formed by additional cleavage in the C-
and D-rings, and in the C-17 side-chain. For example, the
enhanced abundance of fragment ions at m/z 325.26 and
353.26 in the CID spectrum of a monohydroxy-3-oxo-4
C27 steroid (m/z 534.41) are indicative of a 24-hydroxyl
group, and correspond to #f-H and *f-H fragments (Figure
2a, b, and h upper panels, Figure 5a, Scheme 2). Similarly,
the presence of the 25-hydroxyl group in C4-25-ol-3-one
GP hydrazone (VII) can be identified by enhanced abun-
dance of #h-H and *h-H ions at m/z 353.30 and 381.29
(Figure 2c, h right central panel), while an abundant ion at
327.24 (*e  H) is indicative of the 27-hydroxyl group
(Figure 2d). Although these three isomers, and addition-
ally the 7-hydroxy isomers, can be differentiated at low-
resolution on the tandemquadrupole from the above peak
patterns, the identity of the fragment ions requires the
l-3-one GP and C4-24R-ol-3-one GP (green lower
from the brain sample after oxidation and
of m/z 534.41 (retention time 21.04 min) from
llowing oxidation and derivatization. The inset
19.03 min. Spectra were recorded on the Q-TOF24S-o
race)
ctrum
ple fo
g atacquisition of spectra at “moderate”- to “high”-resolution.
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resolution, and the ability to accurately measure peak
centroids, is nicely illustrated in the CID spectra C4-24-
ol-3-one GP hydrazone (VI, Figures 1 and 2h). Shown in
Figure 2h (upper panels) are expanded views of the
peaks in the m/z 325 and 353 regions recorded at
“high-resolution” ( 16,000 FWHM) on the Q-TOF
instruments. At this resolution peaks at m/z 325.23 and
325.26 are fully resolved, respectively. By centroiding
the respective peaks, elemental compositions of
C21H29N2O (*e-H) and C22H33N2 (
#f-H) are determined.
Even when spectra are recorded at “moderate” resolu-
tion (12,000), the accurate mass values are within 10
ppm of the theoretical mass values for these elemental
formulas (data not shown). In the m/z 353 region, just
one peak is observed at m/z 353.26 corresponding to an
elemental composition C23H33N2O (*f-H), and not sur-
prisingly the centroid of this fully resolved peak gives
good agreement with the theoretical mass (2 ppm). The
ability of the Q-TOF instruments to resolve close lying
peaks and accurately measure their position on the m/z
scale is of great value in identifying ion structure.
Further, a knowledge of the elemental composition of
the precursor ion (determined in an independent mass
scan), e.g., C34H52N3O2 for C
4-24-ol-3-one GP hydra-
zone (VI), is used to limit the chemical composition of
possible fragment ions in a search of measured mass
against elemental composition. This improves the spec-
ificity of the search, and effectively means that a mass
accuracy of 10 ppm can allow the unique identification
of most fragment ions.
Most fragment ions in the CID spectra of 3-oxo-4
GP hydrazones are derived from [M-79] or [M-107]
intermediates (Scheme 2). Those derived from the
[M-79] intermediate (indicated by an asterisk) are
modified by the addition of the NNHCOCH2 group
(71.0245 Da) to the steroid skeleton, while those derived
from the [M-107] intermediate (indicated by a hatch, #)
are modified with a NNHCH2 group (43.0296). These
“groups” or “tags” are mass deficient with respect to
moieties made up simply of carbon and hydrogen.
Taking the NNHCOCH2 (71.0245 Da) tag for example,
the hydrocarbon closest in mass is C5H11 at 71.0861 Da,
61.6 mDa (867 ppm) away from the tag. Additionally,
the two tags have different degrees of mass deficiency,
the result of which is that at a given nominal mass, e.g.,
325 (Figure 2h), fragment ions tagged with NNH-
COCH2 (i.e., *e-H, 325.2280 Da) are resolved from those
tagged with NNHCH2 (i.e.,
#f-H, 325.2644 Da) or any
possible hydrocarbon fragments (i.e., C24H37, 325.2895
Da).
As with the monohydroxy-3-oxo-4 steroids, the
MS/MS spectra of the dihydroxy-3-oxo-4 GP hydra-
zones studied allowed isomer differentiation. The pres-
ence of a 7-hydroxyl group is immediately evident by
the altered pattern of B-ring fragments. Somewhat
surprisingly, the C4-7,25-diol-3-one (XIII) isomer gives
a noticeably different spectrum to the C4-7,25-diol-3-
one (XIV) isomer (see Supplementary Material FigureS-1). In the spectrum of the 7 isomer there is enhanced
abundance of the fragment ions at m/z 203.15 (#c2 
2H-H2O) and 231.15 (*c22H-H2O), while in the spec-
trum of the 7 isomer the fragment ion at 341.22 (*e-H)
is enhanced. Significantly, there is also a major differ-
ence in the relative abundance of [M-79-18] and
[M-107-18] ions between these isomers, in that the
dehydration products (m/z 453.15, 425.35) are more
prevalent in the spectrum of the 7 isomer. The pres-
ence of the 7-hydroxyl group in C4-7,27-diol-3-one
(XV) also affects the fragment ion ratio of ions at m/z
203.15, 231.15, and 341.22 in that the abundance of ions
at 203.15 and 231.15 are enhanced (Figure 3a). This
isomer can then be differentiated from the 7,25-diol on
account of the abundance of these fragment ions, and
from the 7,25-diol on account of the abundance of
[M-79-18] fragment (m/z 453.35). The presence of the
25-hydroxyl group results in enhanced dehydration of
the [M-79] fragment ion. The lability of the 25-hy-
droxyl group also enhances the abundance of fragment
ions at m/z 363.31 (C27H39) compared with that at 381.32
(C27H41O), corresponding to quadruply unsaturated
cholestane and triply unsaturated cholestanol skeletons,
respectively (cf. Scheme 5). The MS/MS spectrum of
C4-20R,22R-diol-3-one (XII) is quite different from that
of isomers possessing a 7-hydroxyl group on account of
the pattern of B-ring fragments. Additionally, the pres-
ence of the 20,22-diol structure gives enhanced abun-
dance of ions at m/z 299.25 (#eH), 327.24 (*eH) and
353.26 (*f  H-H2O) (Figure 3b). The 20,22-diol struc-
ture is further characterized by an abundant fragment
ion at m/z 109.10 (C8H13). This ion corresponds to a
side-chain fragment formed by cleavage of the C-17–
C-20 bond, and which is additionally doubly unsatur-
ated by loss of the two water molecules. This ion is
complementary to e-type fragments. The absence of an
abundant ion at m/z 109.10 in the MS/MS of the
dihydroxy-3-oxo-4 steroid GP hydrazone in the brain
sample analyzed (Figure 5b and Supplementary Mate-
rial Figure S-1f) argues against it being a 20,22-diol, and
the pattern of B-ring fragment ions definitely indicates
that the steroid is not 7-hydroxylated. We tentatively
suggest a 24,25-diol, a 24,27-diol or a 25,27-diol struc-
ture (Figure 5b and Supplementary Material Figure
S-1f). The presence of multiple isomers in the brain
sample emphasizes the importance of incorporation of
the LC-MS/MS step (Figure 5).
Although only one dioxosteroid was analyzed in the
current study, i.e., C4-3,20-dione, the MS/MS spectra of
both the bis- and mono-GP hydrazones (X, XI) give
fragment ion information which aid in the location of
the two oxo groups. In earlier studies, we have ob-
served that GP hydrazine reacts faster with the 3-oxo-4
structure than with simple ketones, and the MS/MS
spectrum of the C4-3,22-dione mono-GP (X) confirms
this, i.e., the pattern of b1-12, b2-CH2/b3-C2H4 and b2
B-ring fragment ions is observed (Figure 2f). Addition-
ally, the location of the C-22 ketone is indicated by the
abundant #e-H and *e-H fragments (m/z 297.23, 325.23)
361J Am Soc Mass Spectrom 2006, 17, 341–362 ES-MS/MS OF OXYSTEROLSformed by a McLafferty-type fragmentation of the bond
 to the ketone group. The low-mass region of the
spectrum also gives fragment ions indicative of the
22-oxo group, i.e., at m/z 99.08, (C6H11O, F) and 81.07,
(C6H9, F-H2O). These are cations formed by cleavage of
the C-20–C-22 bond  to the ketone group, without and
with dehydration (cf. Scheme 5). The observation of
these structurally informative low-mass fragment-ions
emphasizes the importance of recording the entire
MS/MS spectrum, not just a portion of it (cf. ion-trap
data). Inspection of the MS/MS spectrum of the bis-
derivative (Figure 2g) reveals a very minor pattern of
B-ring fragments, and a structurally significant frag-
ment at m/z 353.26 (*f-H) formed by cleavage of the
C-20–C-22 bond. Most of the spectrum is dominated by
fragment ions formed by cleavages through the hydra-
zone groups, which are less structurally informative,
but are of value for neutral-loss scanning.
The low-mass region of the MS/MS spectra of ste-
roid GP hydrazones is particularly informative when
the C-17 side-chain contains two hydroxyl groups (Fig-
ure 3b), or an unsaturated group. This is evident in the
spectra of C4-3,22-dione (X) and C4,22-24-ethyl-3-one
(IV) (Figures 2f, 3d). The presence of the C-22–C-23
double-bond in the C4,22-24-ethyl-3-one (IV) structure
results in an abundant fragment at m/z 83.09 (C6H11)
formed by cleavage of the C-23–C-24 bond.
Sensitivity of Analysis
Without derivatization, oxysterols are difficult to ana-
lyze by mass spectrometry. Traditionally, oxysterols are
analyzed by GC-MS after derivatization of the hydroxyl
groups to trimethylsilyl ethers [31, 32]; alternatively
cholesterol-like molecules can be analyzed by ES-MS
and ES-MS/MS after one of a number of different
derivatization reactions [53]. In the current study, mol-
ecules with a C5-3-ol structure have been oxidized to
3-oxo-4 steroids and then derivatized to GP hydra-
zones. Steroids with C5-3-ol structure are extremely
insensitive to ES ionization, and are only observed on
the 100 ng level, 3-oxo-4 steroids give [M  H] ions
and can be observed on the 500 pg level, but further
derivatization to their GP hydrazones gives sub-pg
sensitivity.
As with all analytical methods, there are advantages
and disadvantages; in an attempt to provide an even
handed discussion we draw the attention of the reader
to the following: Only 3-hydroxy-5 and 3-hy-
droxy-5 steroids are oxidized by cholesterol oxidase,
however, steroid dehydrogenases are available that can
be used for other isomers. Oxysterols with a second
substituent in the A-ring are oxidized slowly or perhaps
not at all by cholesterol oxidase. Polyketonic oxysterols
may give multiple derivatives with one or several GP
groups; oxysterols containing an oxo group formed in
vitro should then be analyzed before and after treat-
ment with cholesterol oxidase.The true value of the current procedure is mosteffectively illustrated by the fact that a high quality
MS/MS spectrum of oxidized and derivatized 24-hy-
droxycholesterol were obtained when a sample corre-
sponding to oxysterols extracted from only 40 g of
brain tissue was loaded into the ES capillary or onto C18
capillary column. When the extraction, oxidation and
derivatization procedures have been fully optimized it
can be expected that the amount of tissue required
could be reduced further. This degree of sensitivity
makes oxysterol analysis from tissue biopsies a real
possibility.
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